230 related articles for article (PubMed ID: 8603340)
41. Inactivation of the p15INK4B and p16INK4 genes in hematologic malignancies.
Heyman M; Einhorn S
Leuk Lymphoma; 1996 Oct; 23(3-4):235-45. PubMed ID: 9031104
[TBL] [Abstract][Full Text] [Related]
42. Homozygous deletions but no sequence mutations in coding regions of p15 or p16 in human primary bladder tumors.
Packenham JP; Taylor JA; Anna CH; White CM; Devereux TR
Mol Carcinog; 1995 Nov; 14(3):147-51. PubMed ID: 7576106
[TBL] [Abstract][Full Text] [Related]
43. Infrequent mutations of p16INK4A and p15INK4B genes in human pituitary adenomas.
Yoshimoto K; Tanaka C; Yamada S; Kimura T; Iwahana H; Sano T; Itakura M
Eur J Endocrinol; 1997 Jan; 136(1):74-80. PubMed ID: 9037130
[TBL] [Abstract][Full Text] [Related]
44. Loss of the p16INK4a and p15INK4b genes, as well as neighboring 9p21 markers, in sporadic melanoma.
Flores JF; Walker GJ; Glendening JM; Haluska FG; Castresana JS; Rubio MP; Pastorfide GC; Boyer LA; Kao WH; Bulyk ML; Barnhill RL; Hayward NK; Housman DE; Fountain JW
Cancer Res; 1996 Nov; 56(21):5023-32. PubMed ID: 8895759
[TBL] [Abstract][Full Text] [Related]
45. Regulation of cyclin dependent kinase inhibitor proteins during neonatal cerebella development.
Watanabe G; Pena P; Shambaugh GE; Haines GK; Pestell RG
Brain Res Dev Brain Res; 1998 Jun; 108(1-2):77-87. PubMed ID: 9693786
[TBL] [Abstract][Full Text] [Related]
46. Novel INK4 proteins, p19 and p18, are specific inhibitors of the cyclin D-dependent kinases CDK4 and CDK6.
Hirai H; Roussel MF; Kato JY; Ashmun RA; Sherr CJ
Mol Cell Biol; 1995 May; 15(5):2672-81. PubMed ID: 7739547
[TBL] [Abstract][Full Text] [Related]
47. Biochemical characterization of p16INK4- and p18-containing complexes in human cell lines.
Ragione FD; Russo GL; Oliva A; Mercurio C; Mastropietro S; Pietra VD; Zappia V
J Biol Chem; 1996 Jul; 271(27):15942-9. PubMed ID: 8663131
[TBL] [Abstract][Full Text] [Related]
48. Molecular analysis of alterations of the p18INK4c gene in human meningiomas.
Santarius T; Kirsch M; Nikas DC; Imitola J; Black PM
Neuropathol Appl Neurobiol; 2000 Feb; 26(1):67-75. PubMed ID: 10736068
[TBL] [Abstract][Full Text] [Related]
49. The p19INK4D cyclin dependent kinase inhibitor gene is altered in osteosarcoma.
Miller CW; Yeon C; Aslo A; Mendoza S; Aytac U; Koeffler HP
Oncogene; 1997 Jul; 15(2):231-5. PubMed ID: 9244358
[TBL] [Abstract][Full Text] [Related]
50. Deletion of the p16 and p15 genes in human bladder tumors.
Orlow I; Lacombe L; Hannon GJ; Serrano M; Pellicer I; Dalbagni G; Reuter VE; Zhang ZF; Beach D; Cordon-Cardo C
J Natl Cancer Inst; 1995 Oct; 87(20):1524-9. PubMed ID: 7563186
[TBL] [Abstract][Full Text] [Related]
51. Alterations of INK4A and INK4B genes in adult soft tissue sarcomas: effect on survival.
Orlow I; Drobnjak M; Zhang ZF; Lewis J; Woodruff JM; Brennan MF; Cordon-Cardo C
J Natl Cancer Inst; 1999 Jan; 91(1):73-9. PubMed ID: 9890173
[TBL] [Abstract][Full Text] [Related]
52. Analysis of the p16INK4 and TP53 tumor suppressor genes in bone sarcoma pediatric patients.
Patiño-García A; Sierrasesúmaga L
Cancer Genet Cytogenet; 1997 Oct; 98(1):50-5. PubMed ID: 9309118
[TBL] [Abstract][Full Text] [Related]
53. p16INK4A and p15INK4B gene deletions in primary leukemias.
Haidar MA; Cao XB; Manshouri T; Chan LL; Glassman A; Kantarjian HM; Keating MJ; Beran MS; Albitar M
Blood; 1995 Jul; 86(1):311-5. PubMed ID: 7795238
[TBL] [Abstract][Full Text] [Related]
54. Homozygous deletion of the MTS1/p16 and MTS2/p15 genes and amplification of the CDK4 gene in glioma.
Sonoda Y; Yoshimoto T; Sekiya T
Oncogene; 1995 Nov; 11(10):2145-9. PubMed ID: 7478535
[TBL] [Abstract][Full Text] [Related]
55. Inactivation of cyclin-dependent kinase inhibitor genes and development of human acute leukemias.
Ragione FD; Iolascon A
Leuk Lymphoma; 1997 Mar; 25(1-2):23-35. PubMed ID: 9130611
[TBL] [Abstract][Full Text] [Related]
56. Methylthioadenosine phosphorylase gene deletions are common in osteosarcoma.
García-Castellano JM; Villanueva A; Healey JH; Sowers R; Cordon-Cardo C; Huvos A; Bertino JR; Meyers P; Gorlick R
Clin Cancer Res; 2002 Mar; 8(3):782-7. PubMed ID: 11895909
[TBL] [Abstract][Full Text] [Related]
57. Status and expression of the p16INK4 gene in human thyroid tumors and thyroid-tumor cell lines.
Calabrò V; Strazzullo M; La Mantia G; Fedele M; Paulin C; Fusco A; Lania L
Int J Cancer; 1996 Jul; 67(1):29-34. PubMed ID: 8690521
[TBL] [Abstract][Full Text] [Related]
58. Expression and regulation of G1 cell-cycle inhibitors (p16INK4A, p15INK4B, p18INK4C, p19INK4D) in human acute myeloid leukemia and normal myeloid cells.
Schwaller J; Pabst T; Koeffler HP; Niklaus G; Loetscher P; Fey MF; Tobler A
Leukemia; 1997 Jan; 11(1):54-63. PubMed ID: 9001419
[TBL] [Abstract][Full Text] [Related]
59. Homozygous deletions at chromosome 9p21 and mutation analysis of p16 and p15 in microdissected primary non-small cell lung cancers.
Packenham JP; Taylor JA; White CM; Anna CH; Barrett JC; Devereux TR
Clin Cancer Res; 1995 Jul; 1(7):687-90. PubMed ID: 9816033
[TBL] [Abstract][Full Text] [Related]
60. Prognostic importance of p15INK4B and p16INK4 gene inactivation in childhood acute lymphocytic leukemia.
Heyman M; Rasool O; Borgonovo Brandter L; Liu Y; Grandér D; Söderhäll S; Gustavsson G; Einhorn S
J Clin Oncol; 1996 May; 14(5):1512-20. PubMed ID: 8622065
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
